️🇺🇸🇨🇳 Reuters: The US Treasury Department is drafting rules that will likely allow US pharmaceutical companies to continue investing in promising drugs developed by Chinese companies.

️🇺🇸🇨🇳 Reuters: The US Treasury Department is drafting rules that will likely allow US pharmaceutical companies to continue investing in promising drugs developed by Chinese companies.

The proposed rules would reportedly limit investments involving pathogens or biotechnology that could be used in weapons, while preserving the ability of American companies to hold most licensing and investment deals with Chinese drug developers.